2021 Archive

See how a treatment combo propels Ewing sarcoma radiation therapy to new heights

3D printing of pharmaceuticals is making it easier for pediatric patients to take their medicine.

Treatment for Hodgkin lymphoma led student Evan Moore to a summer spent studying infectious diseases in the laboratory of Victor Torres, PhD.

See how Melissa Hudson, MD, ensures patients have the best quality of life possible after treatment

Find out why cholera pandemics aren’t more common.

Learn how the Gait and Mobility Lab at St. Jude is helping study and care for patients with neurologic disease.

Expanding access to cochlear implants could have large benefits for survivors.

Scientists at St. Jude are utilizing genetic research to transform diagnosis and treatment for children with severe epilepsies.

Learn how St. Jude is accelerating immunotherapy’s path to the clinic.

Through the Pediatric Translational Neuroscience Initiative St. Jude investigators are gaining new understanding and learning how to better treat ataxias.

Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.

Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.